Accessibility Menu
Tristel Plc logo

Tristel Plc(LSE) TSTL

Market Cap£203.11MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2005)+1,342%
5 Year-29%
1 Year+14%
1 Month+10%
£4.24
+0.81%
+0.03Today
Tristel Plc last closing stock price
MetricPriceDate
Last closeGBX 423.502026-08-20
Tristel Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+3.29%GBX 410.002026-08-13
1 month+10%GBX 385.002026-07-21
3 month+10%GBX 385.002026-05-22
Year to date+1.44%GBX 417.502025-12-31
1 year+14.46%GBX 370.002025-08-20
3 year+28.33%GBX 330.002023-08-21
5 year-29.42%GBX 600.002021-08-20
Since inception+1,342.19%GBX 0.292005-06-01

Tristel Plc Financials at a Glance

Market Cap

£203.11MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£93.10M

Net Income (TTM)

£14.00M

EPS (TTM)

£0.16

P/E Ratio

25.64

Dividend

£0.14

Beta (Volatility)

-0.04 (Low)

Price

£4.24

Volume

28,850

Open

£4.21

Previous Close

£4.24

Daily Range

£4.20 - £4.30

52-Week Range

£3.50 - £4.50

Estimated Earnings Date

Oct 19, 2026

TSTL News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Tristel Plc

Tristel PLC is a UK-based company specializing in the development and distribution of infection prevention products. The firm operates in the healthcare sector, focusing on decontamination solutions for medical devices and hospital environments.

Products and Services
  • Disinfection solutions for medical instruments under the Tristel brand
  • Decontamination products for hospital environments
  • Specialized products for various clinical areas, including endoscopy and urology
Growth Outlook
  • Revenue increased to £25.6 million in Q2 2025, up from £23.9 million in Q4 2024
  • Net income rose to £3.95 million in Q2 2025, reflecting strong operational performance
  • Continued expansion into international markets supports long-term growth potential
Financial Highlights
  • Trailing twelve months (TTM) revenue of £100.5 million, indicating consistent growth
  • Net profit margin of 15.9% TTM, showcasing effective cost management
  • Dividend yield of 3.33%, providing attractive returns to shareholders
Tristel PLC has established itself as a leader in infection prevention, with a diverse range of products catering to various medical fields. The company's recent financial performance demonstrates robust growth, particularly in revenue and net income, which are critical indicators of operational efficiency. The strong net profit margin reflects effective cost management strategies, while the attractive dividend yield enhances shareholder value. With ongoing expansion into international markets, Tristel PLC is well-positioned for sustained growth in the healthcare sector.
AI Generated • Aug 2, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

267

CEO

Matthew Giovanni Sassone

Website

www.tristel.com

Headquarters

Newmarket, EA CB8 7NY, GB

TSTL Financials

Key Financial Metrics (TTM)

Gross Margin

78.65%

Operating Margin

19.72%

Net Income Margin

15.88%

Return on Equity

23.64%

Return on Capital

21.60%

Return on Assets

17.31%

Earnings Yield

3.90%

Dividend Yield

3.36%

Payout Ratio

86.18%

Stock Overview

Market Cap

£203.11MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

48.07M

Volume

28.85K

Avg. Volume

152.33K

Financials (TTM)

Gross Profit

£72.22M

Operating Income

£17.02M

EBITDA

£23.12M

Operating Cash Flow

£21.52M

Capital Expenditure

-£2.08M

Free Cash Flow

£19.44M

Cash & ST Invst.

£13.29M

Total Debt

£5.82M

Tristel Plc Performance Analysis

Tristel Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30GBP 31,123,000N/A
20232023-06-30GBP 36,009,00015.7%
20242024-06-30GBP 41,933,00016.5%
20252025-06-30GBP 46,462,00010.8%
Tristel Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30N/A
Q22024-12-31N/A
Q42025-06-30N/A
Q22025-12-31N/A
Tristel Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30GBP 0.02N/A
20232023-06-30GBP 0.09355.1%
20242024-06-30GBP 0.1443.9%
20252025-06-30GBP 0.142.0%
Tristel Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-30N/A
Q22024-12-31N/A
Q42025-06-30N/A
Q22025-12-31N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

£25.65M

+22.5%

Gross Profit

£19.59M

+11.7%

Gross Margin

76.38%

N/A

Market Cap

£203.11MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

£760.71K

N/A

Employees

267

N/A

Net Income

£3.95M

+28.3%

EBITDA

£6.51M

+50.3%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

£13.29M

+23.4%

Total Debt

£5.82M

-2.2%

Accounts Receivable

£8.79M

+28.3%

Inventory

£4.32M

-2.9%

Long Term Debt

£4.71M

-8.3%

Short Term Debt

£1.11M

+36.4%

Return on Assets

17.31%

N/A

Return on Invested Capital

25.03%

N/A

Free Cash Flow

£5.10M

-1.4%

Operating Cash Flow

£5.41M

+0.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
ANCR.LAnimalcare Group plc
£3.35+0.45%
BXP.LBeximco Pharmaceuticals Limited
£0.55-1.79%
OPT.LOptima Health plc
£2.38+0.00%
DXRX.LDiaceutics PLC
£1.37-4.20%

Trending Stocks

Symbol / CompanyPricePrice Chg
BITOProShares Trust - ProShares Bitcoin ETF
$9.81+0.06%
SPCXSpace Exploration Technologies
$134.00-0.04%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.88-0.03%
IBITiShares Bitcoin Trust
$41.20+0.06%

Questions About TSTL

What is the current price of Tristel Plc?

Tristel Plc is trading at £4.24 per share.

What is the 52-week range for Tristel Plc?

Over the past 52 weeks, Tristel Plc has traded between £3.50 and £4.50.

How much debt does Tristel Plc have?

As of the most recent reporting period, Tristel Plc reported total debt of £5.88M.

How much cash does Tristel Plc have on hand?

Tristel Plc reported £12.84M in cash and cash equivalents in its most recent financial results.

What is Tristel Plc’s dividend yield?

Tristel Plc currently has a dividend yield of 3.36%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services